These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32567076)

  • 61. Evaluation of oral minoxidil in the treatment of alopecia areata.
    Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A
    Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oral Minoxidil: A Possible New Therapy for Androgenetic Alopecia.
    Gomolin A; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(1):88-89. PubMed ID: 31994933
    [No Abstract]   [Full Text] [Related]  

  • 63. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
    Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
    J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Maxilène and alopecia].
    Dubertret L
    Ann Dermatol Venereol; 1998 Apr; 125(4):275. PubMed ID: 9747268
    [No Abstract]   [Full Text] [Related]  

  • 65. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
    Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A
    Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia.
    Rietschel RL; Duncan SH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):677-85. PubMed ID: 3549802
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Familial frontal fibrosing alopecia treated with dutasteride, minoxidil and artificial hair transplantation.
    Cranwell WC; Sinclair R
    Australas J Dermatol; 2017 Aug; 58(3):e94-e96. PubMed ID: 27273740
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica.
    Clissold SP; Heel RC
    Drugs; 1987 Feb; 33(2):107-22. PubMed ID: 3552591
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Minoxidil use in dermatology, side effects and recent patents.
    Rossi A; Cantisani C; Melis L; Iorio A; Scali E; Calvieri S
    Recent Pat Inflamm Allergy Drug Discov; 2012 May; 6(2):130-6. PubMed ID: 22409453
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Minoxidil sulfation in the hair follicle.
    Baker CA; Uno H; Johnson GA
    Skin Pharmacol; 1994; 7(6):335-9. PubMed ID: 7946376
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparable efficacy of 2% minoxidil gel and solution formulations in the treatment of male pattern alopecia.
    Piepkorn MW; Weidner M
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1059-62. PubMed ID: 3385024
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
    Walsh DS; Dunn CL; James WD
    Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
    [No Abstract]   [Full Text] [Related]  

  • 73. Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness.
    Rushton DH; Unger WP; Cotterill PC; Kingsley P; James KC
    Clin Exp Dermatol; 1989 Jan; 14(1):40-6. PubMed ID: 2680179
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
    Suchonwanit P; Rojhirunsakool S; Khunkhet S
    Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Topical minoxidil therapy for androgenic alopecia in the Middle East. The Middle-Eastern Topical Minoxidil Study Group.
    Karam P
    Int J Dermatol; 1993 Oct; 32(10):763-6. PubMed ID: 8225726
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study.
    Pumthong G; Asawanonda P; Varothai S; Jariyasethavong V; Triwongwaranat D; Suthipinittharm P; Ingkaninan K; Leelapornpisit P; Waranuch N
    J Dermatolog Treat; 2012 Oct; 23(5):385-92. PubMed ID: 21756154
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss.
    Olsen EA
    J Am Acad Dermatol; 2003 Feb; 48(2):253-62. PubMed ID: 12582397
    [No Abstract]   [Full Text] [Related]  

  • 79. Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
    Sharma A; Surve R; Dhurat R; Sinclair R; Tan T; Zou Y; Müller Ramos P; Wambier C; Verner I; Kovacevic M; Goren A
    J Biol Regul Homeost Agents; 2020; 34(2):659-661. PubMed ID: 32492993
    [No Abstract]   [Full Text] [Related]  

  • 80. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
    Panahi Y; Taghizadeh M; Marzony ET; Sahebkar A
    Skinmed; 2015; 13(1):15-21. PubMed ID: 25842469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.